Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials

Khan, Arif, Faucett, James, Morrison, Shaneta, Brown, Walter A.·2013·JAMA Psychiatry
DOI 10.1001/jamapsychiatry.2013.149

Cited by (109)

Items 101–109 of 109

  1. Antipsychotika
    Otto Benkert · 2014 · Springer eBooks
  2. Elderly and Pharmacological Treatment of PTSD
    Ryan C.W. Hall, Sherif M. Soliman · 2015 · Springer eBooks
  3. Antipsychotika
    Otto Benkert, Martin Hautzinger, Mechthild Graf-Morgenstern, Matthias Johannes Müller · 2016 · Springer eBooks
  4. Psychiatric illness, medical treatment and mortality risk
    2013 · Reactions Weekly
  5. Effectiveness of salivary-gland and oral-mucosa massage in alleviating xerostomia in patients with schizophrenia
    Yuki Iwashima, Yutaka Watanabe, Kimiya Ozaki, Eri Arai, Kazuhito Miura, Ayako Yokoyama, Miyako Kondo, Seitaro Nakazawa, Matsuhiko Oka, Kazutaka Okada et al. · 2024 · Journal of Oral and Maxillofacial Surgery Medicine and Pathology
  6. Literaturverzeichnis zu Voderholzer (Hrsg.): Therapie psychischer Erkrankungen, 20. Auflage
    2024 · Elsevier eBooks
  7. Lurasidone versus typical antipsychotics for schizophrenia
    Dawid Storman, Magdalena Koperny, Krzysztof Styczeń, Wojciech Datka, Rafał Roman Jaeschke · 2025 · Cochrane Database of Systematic Reviews
  8. Evidence-Based Clinical Guide to Suicide Risk and Prevention in People with Bipolar Disorders
    Ayal Schaffer, Rachel H. B. Mitchell, Jasmine Amini, Rosalie J. Steinberg, Mark Sinyor · 2025 · Springer eBooks
  9. Cultural adaptations of a group exercise intervention for diverse outpatients in an urban community to improve exercise engagement and mood outcomes
    Mary Josephine Schadegg, Laurie Gallo, Ana R. Ozdoba, Kristin L. Szuhany · 2025 · Translational Behavioral Medicine